Session 18
Evolving Concepts in Dermatology Part XV

About
Faculty
Learning Objectives
Intended Audience
Accreditation Statement
Credit Designation Statement
Disclosure
Disclaimer

The need for continued education is critical in these uncertain times. Therefore, the co-directors of the Fall Clinical Dermatology Conference are excited to announce our new program: the Fall Clinical Virtual Grand Rounds (FCVGR). This new online series is designed to help maintain the educational opportunities one would have if they were able to attend grand rounds in person.

FCVGR will consist of weekly CME sessions on a variety of dermatological diseases and tools.

This week, we will be coming to you LIVE!
Wednesday, September 9, 2020
8 PM EDT/ 5 PM PDT

EVOLVING CONCEPTS IN DERMATOLOGY PART XV

Cutaneous Complications from PPE

Answers to Important Questions About Therapeutic Approaches in Dermatology

David Cohen, MD, MPH

Faculty

Charles C. and Dorothea E. Harris Professor and Vice Chairman for Clinical Affairs
Ronald O Perelman Department of Dermatology
New York University School of Medicine
New York, NY

James Del Rosso, DO

Faculty

Adjunct Clinical Professor (Dermatology)
Touro University College of Osteopathic Medicine
Henderson, NV

Upon completion of this activity, the participant should be better able to:

Review the sources of potential irritants and allergens causing dermatoses from Personal Protective Equipment
Review existing strategies to mitigate the aggravation of dermatoses from PPE.
Explain broad spectrum versus narrow spectrum oral antibiotic therapy for acne
Define the natural course of untreated molluscum contagiosum lesions and review treatment options for molluscum lesions
Discuss the potential relevance of dual inhibition versus selective inhibition of cytokines and cytokine subsets in the management of atopic dermatitis and psoriasis.

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and Dermatology University. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by educational grants from Almirall, Bristol-Myers Squibb, Lilly, Mayne Pharma, and UCB.

CONFLICTS OF INTEREST/DISCLOSURES

Faculty disclosures to be announced.

[fc+295]

Session 18 Evolving Concepts in Dermatology Part XV

David Cohen, MD, MPH

James Del Rosso, DO

CONFLICTS OF INTEREST/DISCLOSURESFaculty disclosures to be announced.

Session 18
Evolving Concepts in Dermatology Part XV

CONFLICTS OF INTEREST/DISCLOSURES

Faculty disclosures to be announced.